151 related articles for article (PubMed ID: 14613258)
1. Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
Schnitzer TJ
Arthritis Rheum; 2003 Nov; 48(11):3001-3. PubMed ID: 14613258
[No Abstract] [Full Text] [Related]
2. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
Wepner U
MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
[No Abstract] [Full Text] [Related]
3. Arthritis. Timely treatments for an ageless disease.
Lewis C
FDA Consum; 2000; 34(3):27-9, 31-3. PubMed ID: 11521251
[No Abstract] [Full Text] [Related]
4. Characteristics of COX2 inhibitors questioned.
Petit-Zeman S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368654
[No Abstract] [Full Text] [Related]
5. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
6. COX-2 drug may help treat osteoarthritis.
Health News; 2004 Dec; 10(12):13. PubMed ID: 15645573
[No Abstract] [Full Text] [Related]
7. An action plan for relieving joint pain.
Johns Hopkins Med Lett Health After 50; 2001 Mar; 13(1):6-7. PubMed ID: 11232480
[No Abstract] [Full Text] [Related]
8. Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
Bannwarth B; Ravaud P; Dougados M
J Rheumatol; 2003 Feb; 30(2):421-2. PubMed ID: 12583353
[No Abstract] [Full Text] [Related]
9. Trial of tramadol/acetaminophen tablets for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug.
Ellman MH; Curran J
J Rheumatol; 2005 Mar; 32(3):568; author reply 568-9. PubMed ID: 15742426
[No Abstract] [Full Text] [Related]
10. Arthritis guidelines emphasize exercise.
Klippel J
Health News; 2000 Nov; 6(11):3. PubMed ID: 11100673
[No Abstract] [Full Text] [Related]
11. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
12. Second selective COX-2 inhibitor receives marketing approval.
Miller JL
Am J Health Syst Pharm; 1999 Jul; 56(13):1294. PubMed ID: 10683121
[No Abstract] [Full Text] [Related]
13. Cyclooxygenase 2 inhibitors.
Kelley KW; Ramsey LA
Adv Nurse Pract; 2003 Mar; 11(3):22-4. PubMed ID: 12683165
[No Abstract] [Full Text] [Related]
14. The use of COX-2-specific inhibitors: is it all hype or is it evidence based?
Ince A
J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M136-7. PubMed ID: 11253154
[No Abstract] [Full Text] [Related]
15. Reporting of clinical trials of analgesia.
Katz N
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
[No Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 inhibitor treatment of older osteoarthritis patients.
Andersen SJ
Compr Ther; 2003; 29(4):215-23. PubMed ID: 14989043
[TBL] [Abstract][Full Text] [Related]
17. COX-2 and COX-2 enzyme inhibition.
Conti P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
[No Abstract] [Full Text] [Related]
18. [Safe use of anti-inflammatory analgesics].
Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
[No Abstract] [Full Text] [Related]
19. Concluding remarks. C0X-2-selective inhibition: a new advance in pain management.
Korttila K
Eur J Anaesthesiol Suppl; 2002; 25():21-3. PubMed ID: 12596801
[No Abstract] [Full Text] [Related]
20. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
